Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TrueBlue (TBI) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for TrueBlue (TBI) over the last 17 years, with Q2 2025 value amounting to $200000.0.

  • TrueBlue's Asset Writedowns and Impairment fell 9966.48% to $200000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $450000.0, marking a year-over-year decrease of 9925.07%. This contributed to the annual value of $59.7 million for FY2024, which is 52814.74% up from last year.
  • Per TrueBlue's latest filing, its Asset Writedowns and Impairment stood at $200000.0 for Q2 2025, which was down 9966.48% from $250000.0 recorded in Q1 2025.
  • TrueBlue's Asset Writedowns and Impairment's 5-year high stood at $59.7 million during Q2 2024, with a 5-year trough of $15000.0 in Q4 2023.
  • For the 5-year period, TrueBlue's Asset Writedowns and Impairment averaged around $7.0 million, with its median value being $989000.0 (2022).
  • Over the last 5 years, TrueBlue's Asset Writedowns and Impairment had its largest YoY gain of 3273636.36% in 2021, and its largest YoY loss of 9988.18% in 2021.
  • Over the past 5 years, TrueBlue's Asset Writedowns and Impairment (Quarter) stood at $3.6 million in 2021, then tumbled by 69.27% to $1.1 million in 2022, then crashed by 98.65% to $15000.0 in 2023, then skyrocketed by 397726.67% to $59.7 million in 2024, then plummeted by 99.66% to $200000.0 in 2025.
  • Its last three reported values are $200000.0 in Q2 2025, $250000.0 for Q1 2025, and $59.7 million during Q2 2024.